Psychedelics and Primary Care Virtual Panel: REGISTER NOW!

Registration for our virtual panel on is now open, but space is limited.

REGISTER NOW!

Panel: Psychedelics and Primary Care 

Primary care is at the front lines of our mental health crisis and is often the first point of contact for patients struggling with mental health or substance use disorders. Psychedelic-assisted therapy combines an intensive course of psychotherapy with a supported psychedelic medication administration session, and dozens of studies have shown the efficacy of this model for indications such as PTSD, major depression, and alcohol use disorder. MDMA will likely be approved to treat PTSD sometime in 2024, marking the beginning of a new clinical paradigm for helping patients—including many who are experiencing treatment-resistant conditions.  

This panel discussion by and for primary care providers will help clinicians understand their role in helping patients safely access psychedelic-assisted therapy. We will pay special attention to the challenges communities of color might face in accessing these groundbreaking treatments.  

Panelists: 

Moderator: Darron Smith, PhD, PA-C, DFAAPA | Department of Sociology, Teaching Assistant Professor, University of Memphis

Erica Baiden, MD | Primary Care Physician with an emphasis in Behavioral Health, Access and Inclusion

Lynn Marie Morski, MD, JD | President of the Psychedelic Medicine Association, Host of the Psychedelic Medicine Podcast

Andrew Penn, MS, PMHNP | Clinical Professor, UC San Francisco, School of Nursing, Co-founder of OPENurses